论文信息 - Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma - 字舞流文

Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma

E. Thiel | B. Coiffier | R. Herrmann | J. Wolf | W. Kern | C. Porter | R. Capdeville | C. Müller | K. Belhadj | H. Menssen | M. Pless | D. Bootle | I. Sklenar | L. Choi